MLL-ENL Inhibits Polycomb Repressive Complex 1 to Achieve Efficient Transformation of Hematopoietic Cells

Cell Reports

Volumn 3, Issue 5, 2013, Pages 1553-1566

  Maethner, Emanuel ^a   Garcia Cuellar, Maria Paz ^a   Breitinger, Constanze ^a   Takacova, Sylvia ^b   Divoky, Vladimir ^b   Hess, Jay L ^c   Slany, Robert K ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b PALACKÝ UNIVERSITY   (Czech Republic)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BMI1 PROTEIN; MIXED LINEAGE LEUKEMIA PROTEIN; POLYCOMB GROUP PROTEIN; PROTEIN CBX8; PROTEIN ENL; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; CBX8 PROTEIN, HUMAN; ELL PROTEIN, HUMAN; HYBRID PROTEIN; MLL PROTEIN, HUMAN; PROTEIN BINDING; SMALL INTERFERING RNA; TRANSCRIPTION ELONGATION FACTOR;

ANIMAL CELL; ARTICLE; CELL ELONGATION; CELL TRANSFORMATION; CONTROLLED STUDY; GENE ACTIVATION; GENE LOCUS; HEMATOPOIETIC CELL; IN VIVO STUDY; INHIBITION KINETICS; MOUSE; NONHUMAN; POINT MUTATION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CYTOLOGY; DIMERIZATION; GENETICS; HEK293 CELL LINE; HEMATOPOIETIC STEM CELL; HUMAN; METABOLISM; RNA INTERFERENCE;

CELL TRANSFORMATION, NEOPLASTIC; DIMERIZATION; HEK293 CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; MYELOID-LYMPHOID LEUKEMIA PROTEIN; POLYCOMB REPRESSIVE COMPLEX 1; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; RNA INTERFERENCE; RNA, SMALL INTERFERING; TRANSCRIPTIONAL ELONGATION FACTORS;

EID: 84878547644     PISSN: None     EISSN: 22111247     Source Type: Journal    
DOI: 10.1016/j.celrep.2013.03.038     Document Type: Article

References (44)

1. Bitoun E., Oliver P.L., Davies K.E. The mixed-lineage leukemia fusion partner AF4 stimulates RNA polymerase II transcriptional elongation and mediates coordinated chromatin remodeling. Hum. Mol. Genet. 2007, 16:92-106.
2. Dietrich N., Bracken A.P., Trinh E., Schjerling C.K., Koseki H., Rappsilber J., Helin K., Hansen K.H. Bypass of senescence by the polycomb group protein CBX8 through direct binding to the INK4A-ARF locus. EMBO J. 2007, 26:1637-1648.
3. Dietrich N., Lerdrup M., Landt E., Agrawal-Singh S., Bak M., Tommerup N., Rappsilber J., Södersten E., Hansen K. REST-mediated recruitment of polycomb repressor complexes in mammalian cells. PLoS Genet. 2012, 8:e1002494.
4. Eskeland R., Leeb M., Grimes G.R., Kress C., Boyle S., Sproul D., Gilbert N., Fan Y., Skoultchi A.I., Wutz A., Bickmore W.A. Ring1B compacts chromatin structure and represses gene expression independent of histone ubiquitination. Mol. Cell 2010, 38:452-464.
5. Gao Z., Zhang J., Bonasio R., Strino F., Sawai A., Parisi F., Kluger Y., Reinberg D. PCGF homologs, CBX proteins, and RYBP define functionally distinct PRC1 family complexes. Mol. Cell 2012, 45:344-356.
6. García-Cuéllar M.P., Zilles O., Schreiner S.A., Birke M., Winkler T.H., Slany R.K. The ENL moiety of the childhood leukemia-associated MLL-ENL oncoprotein recruits human Polycomb 3. Oncogene 2001, 20:411-419.
7. Garcia-Cuellar M.P., Mederer D., Slany R.K. Identification of protein interaction partners by the yeast two-hybrid system. Methods Mol. Biol. 2009, 538:347-367.
8. Gilchrist D.A., Fromm G., dos Santos G., Pham L.N., McDaniel I.E., Burkholder A., Fargo D.C., Adelman K. Regulating the regulators: the pervasive effects of Pol II pausing on stimulus-responsive gene networks. Genes Dev. 2012, 26:933-944.
9. Gold M.O., Rice A.P. Targeting of CDK8 to a promoter-proximal RNA element demonstrates catalysis-dependent activation of gene expression. Nucleic Acids Res. 1998, 26:3784-3788.
10. Grau D.J., Chapman B.A., Garlick J.D., Borowsky M., Francis N.J., Kingston R.E. Compaction of chromatin by diverse Polycomb group proteins requires localized regions of high charge. Genes Dev. 2011, 25:2210-2221.
11. He N., Liu M., Hsu J., Xue Y., Chou S., Burlingame A., Krogan N.J., Alber T., Zhou Q. HIV-1 Tat and host AFF4 recruit two transcription elongation factors into a bifunctional complex for coordinated activation of HIV-1 transcription. Mol. Cell 2010, 38:428-438.
12. He N., Chan C.K., Sobhian B., Chou S., Xue Y., Liu M., Alber T., Benkirane M., Zhou Q. Human Polymerase-Associated Factor complex (PAFc) connects the Super Elongation Complex (SEC) to RNA polymerase II on chromatin. Proc. Natl. Acad. Sci. USA 2011, 108:E636-E645.
13. Hemenway C.S., de Erkenez A.C., Gould G.C. The polycomb protein MPc3 interacts with AF9, an MLL fusion partner in t(9;11)(p22;q23) acute leukemias. Oncogene 2001, 20:3798-3805.
14. Hock H. A complex Polycomb issue: the two faces of EZH2 in cancer. Genes Dev. 2012, 26:751-755.
15. Krivtsov A.V., Feng Z., Lemieux M.E., Faber J., Vempati S., Sinha A.U., Xia X., Jesneck J., Bracken A.P., Silverman L.B., et al. H3K79 methylation profiles define murine and human MLL-AF4 leukemias. Cancer Cell 2008, 14:355-368.
16. Leach B.I., Kuntimaddi A., Schmidt C.R., Cierpicki T., Johnson S.A., Bushweller J.H. Leukemia fusion target AF9 is an intrinsically disordered transcriptional regulator that recruits multiple partners via coupled folding and binding. Structure 2012, 21:176-183.
17. Margueron R., Reinberg D. The Polycomb complex PRC2 and its mark in life. Nature 2011, 469:343-349.
18. Martin M.E., Milne T.A., Bloyer S., Galoian K., Shen W., Gibbs D., Brock H.W., Slany R., Hess J.L. Dimerization of MLL fusion proteins immortalizes hematopoietic cells. Cancer Cell 2003, 4:197-207.
19. Milne T.A., Martin M.E., Brock H.W., Slany R.K., Hess J.L. Leukemogenic MLL fusion proteins bind across a broad region of the Hox a9 locus, promoting transcription and multiple histone modifications. Cancer Res. 2005, 65:11367-11374.
20. Milne T.A., Zhao K., Hess J.L. Chromatin immunoprecipitation (ChIP) for analysis of histone modifications and chromatin-associated proteins. Methods Mol. Biol. 2009, 538:409-423.
21. Milne T.A., Kim J., Wang G.G., Stadler S.C., Basrur V., Whitcomb S.J., Wang Z., Ruthenburg A.J., Elenitoba-Johnson K.S., Roeder R.G., Allis C.D. Multiple interactions recruit MLL1 and MLL1 fusion proteins to the HOXA9 locus in leukemogenesis. Mol. Cell 2010, 38:853-863.
22. Monroe S.C., Jo S.Y., Sanders D.S., Basrur V., Elenitoba-Johnson K.S., Slany R.K., Hess J.L. MLL-AF9 and MLL-ENL alter the dynamic association of transcriptional regulators with genes critical for leukemia. Exp. Hematol. 2011, 39:77-86. e1-5.
23. Mueller D., Bach C., Zeisig D., Garcia-Cuellar M.P., Monroe S., Sreekumar A., Zhou R., Nesvizhskii A., Chinnaiyan A., Hess J.L., Slany R.K. A role for the MLL fusion partner ENL in transcriptional elongation and chromatin modification. Blood 2007, 110:4445-4454.
24. Mueller D., García-Cuéllar M.P., Bach C., Buhl S., Maethner E., Slany R.K. Misguided transcriptional elongation causes mixed lineage leukemia. PLoS Biol. 2009, 7:e1000249.
25. Muntean A.G., Tan J., Sitwala K., Huang Y., Bronstein J., Connelly J.A., Basrur V., Elenitoba-Johnson K.S., Hess J.L. The PAF complex synergizes with MLL fusion proteins at HOX loci to promote leukemogenesis. Cancer Cell 2010, 17:609-621.
26. Neff T., Sinha A.U., Kluk M.J., Zhu N., Khattab M.H., Stein L., Xie H., Orkin S.H., Armstrong S.A. Polycomb repressive complex 2 is required for MLL-AF9 leukemia. Proc. Natl. Acad. Sci. USA 2012, 109:5028-5033.
27. Nguyen A.T., Zhang Y. The diverse functions of Dot1 and H3K79 methylation. Genes Dev. 2011, 25:1345-1358.
28. Oguro H., Yuan J., Ichikawa H., Ikawa T., Yamazaki S., Kawamoto H., Nakauchi H., Iwama A. Poised lineage specification in multipotential hematopoietic stem and progenitor cells by the polycomb protein Bmi1. Cell Stem Cell 2010, 6:279-286.
29. Peterlin B.M., Price D.H. Controlling the elongation phase of transcription with P-TEFb. Mol. Cell 2006, 23:297-305.
30. Slany R.K. The molecular biology of mixed lineage leukemia. Haematologica 2009, 94:984-993.
31. Smith E., Lin C., Shilatifard A. The super elongation complex (SEC) and MLL in development and disease. Genes Dev. 2011, 25:661-672.
32. So C.W., Cleary M.L. Dimerization: a versatile switch for oncogenesis. Blood 2004, 104:919-922.
33. Sobhian B., Laguette N., Yatim A., Nakamura M., Levy Y., Kiernan R., Benkirane M. HIV-1 Tat assembles a multifunctional transcription elongation complex and stably associates with the 7SK snRNP. Mol. Cell 2010, 38:439-451.
34. Stock J.K., Giadrossi S., Casanova M., Brookes E., Vidal M., Koseki H., Brockdorff N., Fisher A.G., Pombo A. Ring1-mediated ubiquitination of H2A restrains poised RNA polymerase II at bivalent genes in mouse ES cells. Nat. Cell Biol. 2007, 9:1428-1435.
35. Sulong S., Moorman A.V., Irving J.A., Strefford J.C., Konn Z.J., Case M.C., Minto L., Barber K.E., Parker H., Wright S.L., et al. A comprehensive analysis of the CDKN2A gene in childhood acute lymphoblastic leukemia reveals genomic deletion, copy number neutral loss of heterozygosity, and association with specific cytogenetic subgroups. Blood 2009, 113:100-107.
36. Swift S., Lorens J., Achacoso P., Nolan G.P. Rapid production of retroviruses for efficient gene delivery to mammalian cells using 293T cell-based systems. Curr. Protoc. Immunol. 2001, Chapter 10. Unit 10.17C.
37. Taberlay P.C., Kelly T.K., Liu C.C., You J.S., De Carvalho D.D., Miranda T.B., Zhou X.J., Liang G., Jones P.A. Polycomb-repressed genes have permissive enhancers that initiate reprogramming. Cell 2011, 147:1283-1294.
38. Takacova S., Slany R., Bartkova J., Stranecky V., Dolezel P., Luzna P., Bartek J., Divoky V. DNA damage response and inflammatory signaling limit the MLL-ENL-induced leukemogenesis invivo. Cancer Cell 2012, 21:517-531.
39. Tan J., Jones M., Koseki H., Nakayama M., Muntean A.G., Maillard I., Hess J.L. CBX8, a polycomb group protein, is essential for MLL-AF9-induced leukemogenesis. Cancer Cell 2011, 20:563-575.
40. Tanaka S., Miyagi S., Sashida G., Chiba T., Yuan J., Mochizuki-Kashio M., Suzuki Y., Sugano S., Nakaseko C., Yokote K., et al. Ezh2 augments leukemogenicity by reinforcing differentiation blockage in acute myeloid leukemia. Blood 2012, 120:1107-1117.
41. Xia Z.B., Anderson M., Diaz M.O., Zeleznik-Le N.J. MLL repression domain interacts with histone deacetylases, the polycomb group proteins HPC2 and BMI-1, and the corepressor C-terminal-binding protein. Proc. Natl. Acad. Sci. USA 2003, 100:8342-8347.
42. Yokoyama A., Lin M., Naresh A., Kitabayashi I., Cleary M.L. A higher-order complex containing AF4 and ENL family proteins with P-TEFb facilitates oncogenic and physiologic MLL-dependent transcription. Cancer Cell 2010, 17:198-212.
43. Yu M., Mazor T., Huang H., Huang H.T., Kathrein K.L., Woo A.J., Chouinard C.R., Labadorf A., Akie T.E., Moran T.B., et al. Direct recruitment of polycomb repressive complex 1 to chromatin by core binding transcription factors. Mol. Cell 2012, 45:330-343.
44. Zhou W., Zhu P., Wang J., Pascual G., Ohgi K.A., Lozach J., Glass C.K., Rosenfeld M.G. Histone H2A monoubiquitination represses transcription by inhibiting RNA polymerase II transcriptional elongation. Mol. Cell 2008, 29:69-80.